Terms: = Sarcomas AND ERBB3, c-erbB3, 2065, P21860, p180-ErbB3, c-erbB-3, ErbB-3, MDA-BF-1, HER3, p85-sErbB3, MGC88033, p45-sErbB3, ENSG00000065361, erbB3-S
56 results:
1. Phenotype analysis of families with TP53 germline variants at the Center for Familial Breast and Ovarian Cancer, Cologne.
Kast K; Rhiem K; Larsen M; Wappenschmidt B; Schmutzler R
Cancer Med; 2024 Feb; 13(3):e6920. PubMed ID: 38230850
[TBL] [Abstract] [Full Text] [Related]
2. Polypharmacology-based kinome screen identifies new regulators of KSHV reactivation.
Olson AT; Kang Y; Ladha AM; Zhu S; Lim CB; Nabet B; Lagunoff M; Gujral TS; Geballe AP
PLoS Pathog; 2023 Sep; 19(9):e1011169. PubMed ID: 37669313
[TBL] [Abstract] [Full Text] [Related]
3. Clinicopathological and molecular analyses of uterine carcinosarcomas using next-generation sequencing: A single-center experience.
Erdogan EG; Yalta TD; Can N; Süt N; Taştekin E; Usta U; Puyan FÖ; Usturalı Keskin FE; Kurt BB
Indian J Pathol Microbiol; 2023; 66(3):449-455. PubMed ID: 37530323
[TBL] [Abstract] [Full Text] [Related]
4. Inhibition of Erb-B2 Receptor Tyrosine Kinase 3 and Associated Regulatory Pathways Potently Impairs Malignant Peripheral Nerve Sheath Tumor Proliferation and Survival.
Black LE; Longo JF; Anderson JC; Carroll SL
Am J Pathol; 2023 Sep; 193(9):1298-1318. PubMed ID: 37328102
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathological Characteristics of NRG1 Fusion-Positive Solid Tumors in Korean Patients.
Cha YJ; Lee C; Joo B; Kim KA; Lee CK; Shim HS
Cancer Res Treat; 2023 Oct; 55(4):1087-1095. PubMed ID: 37321274
[TBL] [Abstract] [Full Text] [Related]
6. Functional genomics of human clear cell sarcoma: genomic, transcriptomic and chemical biology landscape for clear cell sarcoma.
Rasmussen SV; Wozniak A; Lathara M; Goldenberg JM; Samudio BM; Bickford LR; Nagamori K; Wright H; Woods AD; Chauhan S; Lee CJ; Rudzinski ER; Swift MK; Kondo T; Fisher DE; Imyanitov E; Machado I; Llombart-Bosch A; Andrulis IL; Gokgoz N; Wunder J; Mirotaki H; Nakamura T; Srinivasa G; Thway K; Jones RL; Huang PH; Berlow NE; Schöffski P; Keller C
Br J Cancer; 2023 May; 128(10):1941-1954. PubMed ID: 36959380
[TBL] [Abstract] [Full Text] [Related]
7. A Phase 2 Trial of Afatinib in Patients with Solid Tumors that Harbor Genomic Aberrations in the HER family: The MOBILITY3 Basket Study.
Salawu A; Hansen AR; Spreafico A; Al-Ezzi E; Webster S; Bedard PL; Doi J; Wang L; Siu LL; Abdul Razak AR
Target Oncol; 2022 May; 17(3):271-281. PubMed ID: 35635640
[TBL] [Abstract] [Full Text] [Related]
8. ERBB2 and erbb3 Growth Factor Receptors, Neuregulin-1, CD44 and Ki-67 Proliferation Index in Neurofibromatosis Type 1-associated Peripheral Nerve Sheath Tumors.
Friedrich RE; Nörnberg LKN; Hagel C
Anticancer Res; 2022 May; 42(5):2327-2340. PubMed ID: 35489721
[TBL] [Abstract] [Full Text] [Related]
9. Histopathologic features and molecular genetic landscape of HER2-amplified endometrial carcinomas.
Ross DS; Devereaux KA; Jin C; Lin DY; Zhang Y; Marra A; Makker V; Weigelt B; Ellenson LH; Chui MH
Mod Pathol; 2022 Jul; 35(7):962-971. PubMed ID: 34972830
[TBL] [Abstract] [Full Text] [Related]
10. Comprehensive analysis of the ErbB receptor family in pediatric nervous system tumors and rhabdomyosarcoma.
Varlet P; Bouffet E; Casanova M; Giangaspero F; Antonelli M; Hargrave D; Ladenstein R; Pearson A; Hawkins C; König FB; Rüschoff J; Schmauch C; Bühnemann C; Garin-Chesa P; Schweifer N; Uttenreuther-Fischer M; Gibson N; Ittrich C; Krämer N; Solca F; Stolze B; Geoerger B
Pediatr Blood Cancer; 2022 Jan; 69(1):e29316. PubMed ID: 34546642
[TBL] [Abstract] [Full Text] [Related]
11. HER Tyrosine Kinase Family and Rhabdomyosarcoma: Role in Onset and Targeted Therapy.
De Giovanni C; Landuzzi L; Palladini A; Nicoletti G; Nanni P; Lollini PL
Cells; 2021 Jul; 10(7):. PubMed ID: 34359977
[TBL] [Abstract] [Full Text] [Related]
12. Primary splenic histiocytic sarcoma associated with hemophagocytic lymphohistiocytosis: A case report and review of literature of next-generation sequencing involving FLT3, NOTCH2, and KMT2A mutations.
Montalvo N; Lara-Endara J; Redrobán L; Leiva M; Armijos C; Russo L
Cancer Rep (Hoboken); 2022 May; 5(5):e1496. PubMed ID: 34292677
[TBL] [Abstract] [Full Text] [Related]
13. Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicine.
Rivera M; Fichtner I; Wulf-Goldenberg A; Sers C; Merk J; Patone G; Alp KM; Kanashova T; Mertins P; Hoffmann J; Stein U; Walther W
Neoplasia; 2021 Jan; 23(1):21-35. PubMed ID: 33212364
[TBL] [Abstract] [Full Text] [Related]
14. Racial and Ethnic Differences in Sarcoma Incidence Are Independent of Census-Tract Socioeconomic Status.
Diessner BJ; Weigel BJ; Murugan P; Zhang L; Poynter JN; Spector LG
Cancer Epidemiol Biomarkers Prev; 2020 Nov; 29(11):2141-2148. PubMed ID: 32928933
[TBL] [Abstract] [Full Text] [Related]
15. Genomic Profiling Aids Classification of Diagnostically Challenging Uterine Mesenchymal Tumors With Myomelanocytic Differentiation.
Selenica P; Conlon N; Gonzalez C; Frosina D; Jungbluth AA; Beets-Tan RGH; Rao MK; Zhang Y; Benayed R; Ladanyi M; Solit DB; Chiang S; Hyman DM; Hensley ML; Soslow RA; Weigelt B; Murali R
Am J Surg Pathol; 2021 Jan; 45(1):77-92. PubMed ID: 32889887
[TBL] [Abstract] [Full Text] [Related]
16. Associations of Socioeconomic Status, Public vs Private Insurance, and Race/Ethnicity With Metastatic Sarcoma at Diagnosis.
Diessner BJ; Weigel BJ; Murugan P; Zhang L; Poynter JN; Spector LG
JAMA Netw Open; 2020 Aug; 3(8):e2011087. PubMed ID: 32766799
[TBL] [Abstract] [Full Text] [Related]
17. Clinicopathological and prognostic values of ErbB receptor family amplification in primary osteosarcoma.
Huang Z; Wang SL; Chen H; Shen RK; Li XD; Huang QS; Wu CY; Weng DF; Lin JH
Scand J Clin Lab Invest; 2019 Dec; 79(8):601-612. PubMed ID: 31663373
[TBL] [Abstract] [Full Text] [Related]
18. Advanced development of ErbB family-targeted therapies in osteosarcoma treatment.
Wang W; Zhao HF; Yao TF; Gong H
Invest New Drugs; 2019 Feb; 37(1):175-183. PubMed ID: 30353245
[TBL] [Abstract] [Full Text] [Related]
19.
Kendall GC; Watson S; Xu L; LaVigne CA; Murchison W; Rakheja D; Skapek SX; Tirode F; Delattre O; Amatruda JF
Elife; 2018 Jun; 7():. PubMed ID: 29869612
[TBL] [Abstract] [Full Text] [Related]
20. Malignant Gliomas as Second Neoplasms in Pediatric Cancer Survivors: Neuropathological Study.
Izycka-Swieszewska E; Bien E; Stefanowicz J; Szurowska E; Szutowicz-Zielinska E; Koczkowska M; Sigorski D; Kloc W; Rogowski W; Adamkiewicz-Drozynska E
Biomed Res Int; 2018; 2018():4596812. PubMed ID: 29805974
[TBL] [Abstract] [Full Text] [Related]
[Next]
